Webinar 2:
Thursday, March 19, 2009
12 pm ET • 90 minutes
Biomarker Data’s Influence on Reimbursement:
How Can Payors use Biomarkers in Coverage Decison-making?

Biomarker data has the potential to influence the adoption and reimbursement of a given medicine, and payers may be the most logical partners for start-ups interested in developing novel and potentially costly diagnostics. How can biopharma firms demonstrate to payers that biomarker testing lowers their overall health care costs? How do the payers view the pharmacogenomics boom? This panel will explore how health insurers can incorporate biomarkers into their coverage decisions and provide insights into why they are or are not prepared to pay for testing.

FEATURING:

Felix Frueh VP of Research and Development, Personalized Medicine Medco Health Solutions

Robert Seidman President Doc Rock Presents Former VP and Chief Pharmacy Offficer WellPoint Inc.

Alan B. Rosenberg, MD Vice President of Medical Policy, Technology Assessment & Credentialing Programs WellPoint Inc.

______________________________________________________________________

Join us for a thought-provoking analysis of this evolving concept! Grab your team, a phone and a computer with Web access (that last one's optional). No travel required.

Audio recording only: $499

REGISTER

Register for the live webinar, the live webinar PLUS the audio recording or the audio recording only!

Back to top
______________________________________________________________________

FDC-Windhover
P.O. Box 7247
Philadelphia, PA 19101-9257
* Tel: +1 (800) 332-2181
* Fax: +1 (908) 547-2165